why choose us

Clinical Trials Search

Showing 15,850 of 132,656 result(s)
Prospective Observational Study on the Incidence of Opportunistic Fungal Infections

Status: Completed

Condition: Pneumocystis Jirovecii Infection

Interventions:

Date: 2023-01-20

Pilot Study of Nivolumab w;Ipilimumab or Relatlimab in Surgically Resectable Melanoma Brain Metastases

Status: Completed

Condition: Metastatic Melanoma

Interventions: Nivolumab is a monoclonal antibody o PD-1 protein, which is normally express on the surface of activated T cells.
The interaction of PD-1 with it

Date: 2023-01-20

Immunomodulatory Effects of PCSK9 Inhibition

Status: NOT_YET_RECRUITING

Condition: Atherosclerotic Cardiovascular Disease

Interventions: Allows for non-invasive assessment of atherosclerotic plaque burden and morphology

Date: 2023-01-20

Study Evaluating the Safety and Tolerability of RCT1100 in Healthy and PCD Subjects

Status: Completed

Condition: Primary Ciliary Dyskinesia

Interventions: RCT1100 mRNA therapy supplied as varying dose strengths administered via oral inhalation using nebulizer

Date: 2023-01-20

MeMed BV® Test Evaluation in Adult Emergency Department Patients

Status: ACTIVE_NOT_RECRUITING

Condition: Respiratory Infection

Interventions: The MeMed BV® test is an automated semiquantitative immunoassay that measures three nonmicrobial (host) proteins (TRAIL, IP-10, and CRP) in serum samp

Date: 2023-01-20

A Study to Evaluate Rocatinlimab (AMG 451) in Adolescent Subjects With Moderate-to-severe Atopic Dermatitis (AD)

Status: Completed

Condition: Atopic Dermatitis

Interventions: Subcutaneous (SC) injection

Date: 2023-01-20

STRIDE: Stress Reduction in Dementia Caregivers

Status: Completed

Condition: Caregiver Stress

Interventions: Participants assigned to the HMP group will be asked to complete a minimum of 10 minutes per day of meditation for 12 weeks.
For the first four w

Date: 2023-01-20

Effectiveness of Outpatient Intravenous Diuretic Therapy for Treatment of Worsening Heart Failure (OUTPATIENT-WHF)

Status: Completed

Condition: Heart Failure

Interventions: Management strategy including IV diuretic in the outpatient clinic

Date: 2023-01-20

A Study to Evaluate ABP 938 and Aflibercept (Eylea®) in Participants With Chorioretinal Vascular Disease (CVD)

Status: COMPLETED

Condition: Chorioretinal Vascular Disease

Interventions: IVT injection

Date: 2023-01-20

A First-In-Human SAD and MAD Study to Evaluate the Safety, Tolerability, PK and PD of SC Administered ALTB-268 in Healthy Volunteers

Status: Completed

Condition: Healthy Volunteers

Interventions: monoclonal antibody

Date: 2023-01-20